Knocking down schistosomes - promise for lentiviral transduction in parasites

Trends in Parasitology

Volumn 31, Issue 7, 2015, Pages 324-332

  Hagen, Jana ^a   Scheerlinck, Jean Pierre Y ^a   Gasser, Robin B ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Helminth; MicroRNA; RNA interference; Schistosoma; Short interfering RNA

Indexed keywords

DOUBLE STRANDED RNA; MICRORNA;

FUNCTIONAL GENOMICS; GENE SILENCING; HOST PARASITE INTERACTION; LENTIVIRINAE; NONHUMAN; REVIEW; RNA INTERFERENCE; SCHISTOSOMA; SCHISTOSOMA MANSONI; TRANSGENICS; VIRAL GENE DELIVERY SYSTEM; ANIMAL; GENETICS; PATHOGENICITY; SCHISTOSOMIASIS;

LENTIVIRUS; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMATIDAE; VERMES;

ANIMALS; LENTIVIRUS; RNA INTERFERENCE; RNA, DOUBLE-STRANDED; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

EID: 84937519625     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.03.009     Document Type: Review

References (98)

1. Hotez P.J., et al. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 2008, 118:1311-1321.
2. Gryseels B., et al. Human schistosomiasis. Lancet 2006, 368:1106-1118.
3. Rollinson D. A wake up call for urinary schistosomiasis: reconciling research effort with public health importance. Parasitology 2009, 136:1593-1610.
4. Doenhoff M.J., et al. Resistance of Schistosoma mansoni to praziquantel: is there a problem?. Trans. R. Soc. Trop. Med. Hyg. 1999, 96:465-469.
5. Schramm G., Haas H. Th2 immune response against Schistosoma mansoni infection. Microbes Infect. 2010, 12:881-888.
6. Burke M.L., et al. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 2009, 31:163-176.
7. Caldas I.R., et al. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection. Acta Trop. 2008, 108:109-117.
8. Berriman M., et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358.
9. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 2009, 460:345-351. The Schistosoma japonicum genome sequencing and functional analysis consortium.
10. Young N.D., et al. Whole-genome sequence of Schistosoma haematobium. Nat. Genet. 2012, 44:221-225.
11. Rinaldi G., et al. Germline transgenesis and insertional mutagenesis in Schistosoma mansoni mediated by murine leukemia virus. PLoS Pathog. 2012, 8:e1002820.
12. Hagen J., et al. Functional genomics approaches in parasitic helminths. Parasite Immunol. 2012, 34:163-182.
13. Mann V.H., et al. Pseudotyped murine leukemia virus for schistosome transgenesis: approaches, methods and perspectives. Transgenic Res. 2014, 23:539-556.
14. Boyle J. Gene manipulation in parasitic helminths. Int. J. Parasitol. 2003, 33:1259-1268.
15. Jackson A.L., et al. Widespread siRNA 'off-target' transcript silencing mediated by seed region sequence complementarity. RNA 2006, 12:1179-1187.
16. Khan A., et al. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009, 27:549-555.
17. Dalzell J.J., et al. Considering RNAi experimental design in parasitic helminths. Parasitology 2012, 139:589-604.
18. Geldhof P., et al. RNA interference in parasitic helminths: current situation, potential pitfalls and future prospects. Parasitology 2007, 134:609-619.
19. Skelly P.J., et al. Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int. J. Parasitol. 2003, 33:363-369.
20. Ndegwa D., et al. Protocols for gene silencing in schistosomes. Exp. Parasitol. 2007, 117:284-291.
21. Zhang J., Hua Z.C. Targeted gene silencing by small interfering RNA-based knock-down technology. Curr. Pharm. Biotechnol. 2004, 5:1-7.
22. Grimm D., Kay M.A. Combinatorial RNAi: a winning strategy for the race against evolving targets?. Mol. Ther. 2007, 15:878-888.
23. Beckmann S., et al. Discovery of platyhelminth-specific α/β-integrin families and evidence for their role in reproduction in Schistosoma mansoni. PLoS ONE 2012, 7:e52519.
24. Correnti J.M., et al. Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol. Biochem. Parasitol. 2005, 143:209-215.
25. Krautz-Peterson G., et al. Optimizing gene suppression in schistosomes using RNA interference. Mol. Biochem. Parasitol. 2007, 153:194-202.
26. Stefanić S., et al. RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl. Trop. Dis. 2010, 4:e850.
27. Dinguirard N., Yoshino T.P. Potential role of a CD36-like class B scavenger receptor in the binding of modified low-density lipoprotein (acLDL) to the tegumental surface of Schistosoma mansoni sporocysts. Mol. Biochem. Parasitol. 2006, 146:219-230.
28. Krautz-Peterson G., et al. Suppressing glucose transporter gene expression in schistosomes impairs parasite feeding and decreases survival in the mammalian host. PLoS Pathog. 2010, 6:e1000932.
29. Morales M., et al. RNA interference of Schistosoma mansoni cathepsin D, the apical enzyme of the hemoglobin proteolysis cascade. Mol. Biochem. Parasitol. 2008, 157:160-168.
30. Delcroix M., et al. A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite. J. Biol. Chem. 2006, 281:39316-39329.
31. Tchoubrieva E.B., et al. Vector-based RNA interference of cathepsin B1 in Schistosoma mansoni. Cell. Mol. Life Sci. 2010, 67:3739-3748.
32. Krautz-Peterson G., Skelly P.J. Schistosome asparaginyl endopeptidase (legumain) is not essential for cathepsin B1 activation in vivo. Mol. Biochem. Parasitol. 2008, 159:54-58.
33. Tran M.H., et al. Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog. 2010, 6:e1000840.
34. Beckmann S., et al. The Syk kinase SmTK4 of Schistosoma mansoni is involved in the regulation of spermatogenesis and oogenesis. PLoS Pathog. 2010, 6:e1000769.
35. Osman A., et al. Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene. PLoS Pathog. 2006, 2:e54.
36. Kuntz A.N., et al. Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med. 2007, 4:e206.
37. Mourão M.M., et al. Phenotypic screen of early-developing larvae of the blood fluke, Schistosoma mansoni, using RNA interference. PLoS Negl. Trop. Dis. 2009, 3:e502.
38. Freitas T.C., et al. TGF-beta signaling controls embryo development in the parasitic flatworm Schistosoma mansoni. PLoS Pathog. 2007, 3:e52.
39. Rinaldi G., et al. RNA interference targeting leucine aminopeptidase blocks hatching of Schistosoma mansoni eggs. Mol. Biochem. Parasitol. 2009, 167:118-126.
40. Krautz-Peterson G., et al. RNA interference in schistosomes: machinery and methodology. Parasitology 2010, 137:485-495.
41. Correnti J.M., et al. Transfection of Schistosoma mansoni by electroporation and the description of a new promoter sequence for transgene expression. Int. J. Parasitol. 2007, 37:1107-1115.
42. Correnti J.M., Pearce E.J. Transgene expression in Schistosoma mansoni: introduction of RNA into schistosomula by electroporation. Mol. Biochem. Parasitol. 2004, 137:75-79.
43. Beckmann S., et al. Schistosoma mansoni: germ-line transformation approaches and actin-promoter analysis. Exp. Parasitol. 2007, 117:292-303.
44. Davis R.E., et al. Transient expression of DNA and RNA in parasitic helminths by using particle bombardment. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8687-8692.
45. Heyers O., et al. Schistosoma mansoni miracidia transformed by particle bombardment infect Biomphalaria glabrata snails and develop into transgenic sporocysts. Exp. Parasitol. 2003, 105:174-178.
46. Wippersteg V., et al. HSP70-controlled GFP expression in transiently transformed. Mol. Biochem. Parasitol. 2002, 120:141-150.
47. Rossi A., et al. Cloning of 5' and 3' flanking regions of the Schistosoma mansoni calcineurin A gene and their characterization in transiently transformed parasites. Mol. Biochem. Parasitol. 2003, 130:133-138.
48. Wippersteg V., et al. Characterisation of the cysteine protease ER60 in transgenic Schistosoma mansoni larvae. Int. J. Parasitol. 2002, 32:1219-1224.
49. Wippersteg V., et al. The uptake of Texas Red-BSA in the excretory system of schistosomes and its colocalisation with ER60 promoter-induced GFP in transiently transformed adult males. Int. J. Parasitol. 2003, 33:1139-1143.
50. Dvorák J., et al. Biolistic transformation of Schistosoma mansoni: studies with modified reporter-gene constructs containing regulatory regions of protease genes. Mol. Biochem. Parasitol. 2010, 170:37-40.
51. Morales M.E., et al. piggyBac transposon mediated transgenesis of the human blood fluke, Schistosoma mansoni. FASEB J. 2007, 21:3479-3489.
52. Mann V.H., et al. Transgenesis of schistosomes: approaches employing mobile genetic elements. Parasitology 2008, 135:141-153.
53. Kines K., et al. Transduction of Schistosoma mansoni by vesicular stomatitis virus glycoprotein-pseudotyped Moloney murine leukemia retrovirus. Exp. Parasitol. 2006, 112:209-220.
54. Burns J.C., et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8033-8037.
55. Schambach A., et al. Biosafety features of lentiviral vectors. Hum. Gene Ther. 2013, 24:132-142.
56. Kines K., et al. Integration of reporter transgenes into Schistosoma mansoni chromosomes mediated by pseudotyped murine leukemia virus. FASEB J. 2008, 22:2936-2948.
57. Kines K., et al. Electroporation facilitates introduction of reporter transgenes and virions into schistosome eggs. PLoS Negl. Trop. Dis. 2010, 4:e593.
58. Jurberg A.D., et al. The embryonic development of Schistosoma mansoni eggs: proposal for a new staging system. Dev. Genes Evol. 2009, 219:219-234.
59. Duvoisin R., et al. Human U6 promoter drives stronger shRNA activity than its schistosome orthologue in Schistosoma mansoni and human fibrosarcoma cells. Transgenic Res. 2012, 21:511-521.
60. Ayuk M., et al. Schistosoma mansoni U6 gene promoter-driven short hairpin RNA induces RNA interference in human fibrosarcoma cells and schistosomules. Int. J. Parasitol. 2011, 41:783-789.
61. Hagen J., et al. Omega-1 knockdown in Schistosoma mansoni eggs by lentivirus transduction reduces granuloma size in vivo. Nat. Commun. 2014, 5:5375.
62. Zhao Z., et al. Schistosoma japonicum: inhibition of Mago nashi gene expression by shRNA-mediated RNA interference. Exp. Parasitol. 2008, 119:379-384.
63. Fedorov Y., et al. Off-target effects by siRNA can induce toxic phenotype. RNA 2006, 12:1188-1196.
64. Boudreau R.L., et al. Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs. RNA 2008, 14:1834-1844.
65. Zeng Y., Cullen B.R. Sequence requirements for micro RNA processing and function in human cells. RNA 2003, 9:112-123.
66. Zeng Y., et al. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 2002, 9:1327-1333.
67. Silva J.M., et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat. Genet. 2005, 37:1281-1288.
68. Paddison P.J., et al. Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat. Methods 2004, 1:163-167.
69. Khvorova A., et al. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
70. Vert J-P., et al. An accurate and interpretable model for siRNA efficacy prediction. BMC Bioinform. 2006, 7:520.
71. Nienhuis A.W., et al. Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther. 2006, 13:1031-1049.
72. Maetzig T., et al. Gammaretroviral vectors: biology, technology and application. Viruses 2011, 3:677-713.
73. Grimm D. The dose can make the poison: lessons learned from adverse in vivo toxicities caused by RNAi overexpression. Silence 2011, 2:8.
74. Collins Iii J.J., et al. Adult somatic stem cells in the human parasite Schistosoma mansoni. Nature 2013, 494:476-479.
75. Birmingham A., et al. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat. Methods 2006, 3:199-204.
76. Anderson E.M., et al. Experimental validation of the importance of seed complement frequency to siRNA specificity. RNA 2008, 14:853-861.
77. Nielsen C.B., et al. Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA 2007, 13:1894-1910.
78. Xue X., et al. Identification and characterization of novel microRNAs from Schistosoma japonicum. PLoS ONE 2008, 3:e4034.
79. Copeland C.C., et al. Homology-based annotation of non-coding RNAs in the genomes of Schistosoma mansoni and Schistosoma japonicum. BMC Genomics 2009, 10:464.
80. Gomes M.S., et al. Preliminary analysis of miRNA pathway in Schistosoma mansoni. Parasitol. Int. 2009, 58:61-68.
81. Zaiss A., et al. RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy. J. Virol. 2002, 76:7209-7219.
82. Hacein-Bey-Abina S., et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
83. Modlich U., et al. Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16. Leukemia 2008, 22:1519-1528.
84. Li Z., et al. Murine leukemia induced by retroviral gene marking. Science 2002, 296:497.
85. Manjunath N., et al. Lentiviral delivery of short hairpin RNAs. Adv. Drug Deliv. Rev. 2009, 61:732-745.
86. Pauwels K., et al. State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations. Curr. Gene Ther. 2009, 9:459-474.
87. Zufferey R., et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 1998, 72:9873-9880.
88. Hope T. Improving the post-transcriptional aspects of lentiviral vectors. Curr. Top. Microbiol. Immunol. 2002, 261:179-189.
89. Schambach A., et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 2006, 13:641-645.
90. Zufferey R., et al. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 1999, 73:2886-2892.
91. Schambach A., et al. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol. Ther. 2007, 15:1167-1173.
92. Hanawa H., et al. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element. Mol. Ther. 2009, 17:667-674.
93. Suttiprapa S., et al. Prototypic chromatin insulator cHS4 protects retroviral transgene from silencing in Schistosoma mansoni. Transgenic Res. 2012, 21:555-566.
94. Despommier D.D., et al. Parasitic Diseases 1995, Springer.
95. He L., Hannon G.J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Gen. 2004, 5:522-531.
96. Wu X., et al. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300:1749-1751.
97. Bushman F., et al. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 2005, 3:848-858.
98. Wanisch K., Yáñez-Muñoz R.J. Integration-deficient lentiviral vectors: a slow coming of age. Mol. Ther. 2009, 17:1316-1332.